Peri-implant Conditions Mimic Periodontal Conditions

Sponsor
Abant Izzet Baysal University (Other)
Overall Status
Completed
CT.gov ID
NCT06128850
Collaborator
(none)
143
1
8.9
16.1

Study Details

Study Description

Brief Summary

Except for patients with referred clinical bruxism and uncontrolled medical conditions, the study included 123 implants with implanted fixed prostheses that had lasted at least six months after functional prosthetic loading. In all implant patients, the health scale ranged from implants and natural teeth to plaque, gingival index, bleeding in the probe, mouth depth, loss of clinical attachment, and dental implants. The health and illness of the implants have been determined. Patients were divided into three groups: peri-implantitis, peri-implant mucositis, and peri-implant health.

Inclusion Criteria:
  • Patients between the ages of 18- 70

  • Drugs that have a systemically healthy and controlled treatment situation

  • Drivers who have implant-supported fixed prostheses that have been at least six months after functional prosthetic loading Among these groups, it was checked whether periodontitis was seen in patients with peri-implantitis, gingivitis in patients with peri-implant mucositis, and whether healthy gums were seen in individuals with peri-implant health.

To determine the health and disease status of individuals' implants, plaque index (Silness Loe 1964), gingival index (Loe Silness 1963), bleeding on probing (Ainoma Bay 1975), pocket depth measurements, and clinical attachment level were collected.

Condition or Disease Intervention/Treatment Phase
  • Other: disease

Study Design

Study Type:
Observational
Actual Enrollment :
143 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Peri-implant Health and Disease Mimic Periodontal Health and Disease
Actual Study Start Date :
Jul 4, 2022
Actual Primary Completion Date :
Jul 4, 2022
Actual Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Peri-implantitis

Other: disease
compare to diseases

Peri-implant mucositis

Other: disease
compare to diseases

Peri-implant health

Other: disease
compare to diseases

Outcome Measures

Primary Outcome Measures

  1. Plaque index [Baseline]

    The plaque index assesses the amount of dental plaque visible on the vestibular and lingual surfaces of all teeth

  2. Gingival index [Baseline]

    This measurement is based on the presence or absence of bleeding on gentle probing

  3. Bleeding on probing [Baseline]

    Bleeding, leading sign of inflammation inside the connective tissue, is a critical factor for pocket depth measurements, and with other variable factors prevents making reproducible measurements.

Secondary Outcome Measures

  1. Periodontal pocket depth [Baseline]

    a pathologically deepened gingival sulcus around a tooth at the gingival margin.

  2. Clinical attachment level [Baseline]

    CAL is calculated by subtracting the gingival margin level from the probing depth.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients between the ages of 18- 70

  • Drugs that have a systemically healthy and controlled treatment situation

  • Drivers who have implant-supported fixed prostheses that have been at least six months after functional prosthetic loading

Exclusion Criteria:
  • Bruxism

  • Uncontrolled medical conditions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bolu Abant İzzet Baysal University Bolu Turkey

Sponsors and Collaborators

  • Abant Izzet Baysal University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tuğba ŞAHİN, Assistant professor, Abant Izzet Baysal University
ClinicalTrials.gov Identifier:
NCT06128850
Other Study ID Numbers:
  • 2022/163
First Posted:
Nov 13, 2023
Last Update Posted:
Nov 13, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2023